These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11470959)

  • 1. Progress in the modeling of neurodegenerative diseases in transgenic mice.
    Duff K; Rao MV
    Curr Opin Neurol; 2001 Aug; 14(4):441-7. PubMed ID: 11470959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in animal models of human neurodegenerative diseases.
    Guyer C
    Toxicol Pathol; 2000; 28(2):363-6. PubMed ID: 10805156
    [No Abstract]   [Full Text] [Related]  

  • 3. CAG repeat disorder models and human neuropathology: similarities and differences.
    Yamada M; Sato T; Tsuji S; Takahashi H
    Acta Neuropathol; 2008 Jan; 115(1):71-86. PubMed ID: 17786457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic mouse models of neurodegenerative diseases.
    Trancikova A; Ramonet D; Moore DJ
    Prog Mol Biol Transl Sci; 2011; 100():419-82. PubMed ID: 21377633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-Targeting Delivery of Two Peptidylic Inhibitors for Their Combination Therapy in Transgenic Polyglutamine Disease Mice via Intranasal Administration.
    Yang M; Zhang Q; Wang Q; Sørensen KK; Boesen JT; Ma SY; Jensen KJ; Kwan KM; Ngo JCK; Chan HYE; Zuo Z
    Mol Pharm; 2018 Dec; 15(12):5781-5792. PubMed ID: 30392378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making degeneration specific.
    Narasimhan K
    Nat Med; 2001 Nov; 7(11):1184. PubMed ID: 11689879
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic neurodegenerative diseases: the human illness and transgenic models.
    Price DL; Sisodia SS; Borchelt DR
    Science; 1998 Nov; 282(5391):1079-83. PubMed ID: 9804539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional genomics approaches to neurodegenerative diseases.
    Rubinsztein DC
    Mamm Genome; 2008 Sep; 19(9):587-90. PubMed ID: 18665420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse.
    Lee HG; Casadesus G; Nunomura A; Zhu X; Castellani RJ; Richardson SL; Perry G; Felsher DW; Petersen RB; Smith MA
    Am J Pathol; 2009 Mar; 174(3):891-7. PubMed ID: 19164506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder.
    Van Dam D; Vloeberghs E; Abramowski D; Staufenbiel M; De Deyn PP
    CNS Spectr; 2005 Mar; 10(3):207-22. PubMed ID: 15744222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyotrophic lateral sclerosis/parkinsonism dementia complex: transgenic mice provide insights into mechanisms underlying a common tauopathy in an ethnic minority on Guam.
    Trojanowski JQ; Ishihara T; Higuchi M; Yoshiyama Y; Hong M; Zhang B; Forman MS; Zhukareva V; Lee VM
    Exp Neurol; 2002 Jul; 176(1):1-11. PubMed ID: 12093078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
    Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
    Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases.
    Langenfurth A; Rinnenthal JL; Vinnakota K; Prinz V; Carlo AS; Stadelmann C; Siffrin V; Peaschke S; Endres M; Heppner F; Glass R; Wolf SA; Kettenmann H
    J Neurosci Res; 2014 Mar; 92(3):275-86. PubMed ID: 24323769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of mitochondria in inherited neurodegenerative diseases.
    Kwong JQ; Beal MF; Manfredi G
    J Neurochem; 2006 Jun; 97(6):1659-75. PubMed ID: 16805775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degenerative myelopathy associated with a missense mutation in the superoxide dismutase 1 (SOD1) gene progresses to peripheral neuropathy in Pembroke Welsh corgis and boxers.
    Shelton GD; Johnson GC; O'Brien DP; Katz ML; Pesayco JP; Chang BJ; Mizisin AP; Coates JR
    J Neurol Sci; 2012 Jul; 318(1-2):55-64. PubMed ID: 22542607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What transgenic mice tell us about neurodegenerative disease.
    Gurney ME
    Bioessays; 2000 Mar; 22(3):297-304. PubMed ID: 10684590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Animal models of neurodegenerative diseases].
    Langui D; Lachapelle F; Duyckaerts C
    Med Sci (Paris); 2007 Feb; 23(2):180-6. PubMed ID: 17291428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine models for human genetic neurodegenerative diseases.
    Barsoum SC; Callahan HM; Robinson K; Chang PL
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Jul; 24(5):811-23. PubMed ID: 11191715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key?
    Walker LC; Bian F; Callahan MJ; Lipinski WJ; Durham RA; LeVine H
    Amino Acids; 2002; 23(1-3):87-93. PubMed ID: 12373522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases.
    Nagai Y; Fujikake N; Popiel HA; Wada K
    Curr Pharm Biotechnol; 2010 Feb; 11(2):188-97. PubMed ID: 20166962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.